Adachi Yasuhiro, Sato Norihiro, Oba Takuya, Amaike Takao, Kudo Yuzan, Kohi Shiro, Nakayama Toshiyuki, Hirata Keiji
Department of Surgery I, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 807-8555, Japan.
Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 807-8555, Japan.
Oncol Lett. 2022 May 23;24(1):222. doi: 10.3892/ol.2022.13343. eCollection 2022 Jul.
Hyaluronan-binding protein 1 (HABP1) is among the molecules known to bind to hyaluronan and is involved in a variety of cellular processes, including cell proliferation and migration. HABP1 has been implicated in the progression of various cancers; however, there have been (to the best of our knowledge) few studies on the expression and function of HABP1 in pancreatic ductal adenocarcinoma (PDAC), a topic that is examined in the present study. Immunohistochemical analysis of HABP1 protein was conducted in archival tissues from 105 patients with PDAC. Furthermore, the functional effect of HABP1 on proliferation, colony formation, and migration in PDAC cells was examined by knockdown of . It was revealed that HABP1 was overexpressed in 49 (46.2%) out of 105 patients with PDAC. Overall survival was significantly shorter in patients with high HABP1 expression than in those with low HABP1 expression (median survival time of 12.8 months vs. 28.5 months; log-rank test, P=0.004). Knockdown of expression in PDAC cells resulted in decreased cell proliferation, colony formation, and cell migration activity. Thus, HABP1 may serve as a prognostic factor in PDAC and may be of use as a novel therapeutic target.
透明质酸结合蛋白1(HABP1)是已知能与透明质酸结合的分子之一,参与多种细胞过程,包括细胞增殖和迁移。HABP1与多种癌症的进展有关;然而,据我们所知,关于HABP1在胰腺导管腺癌(PDAC)中的表达和功能的研究很少,本研究对此进行了探讨。对105例PDAC患者的存档组织进行了HABP1蛋白的免疫组织化学分析。此外,通过敲低HABP1来检测其对PDAC细胞增殖、集落形成和迁移的功能影响。结果显示,105例PDAC患者中有49例(46.2%)HABP1过表达。HABP1高表达患者的总生存期明显短于低表达患者(中位生存时间分别为12.8个月和28.5个月;对数秩检验,P=0.004)。敲低PDAC细胞中的HABP1表达导致细胞增殖、集落形成和细胞迁移活性降低。因此,HABP1可能作为PDAC的一个预后因素,并且可能用作一种新的治疗靶点。